Vireo Health International (CSE: VREO) (OTCQX: VREOF) - Investor Dashboard
| ➔ Vireo Health | |||||
|---|---|---|---|---|---|
| CSE Ticker: | VREO | ||||
| OTCQX Ticker: | VREOF | ||||
| Market Focus: | United States |
| Classification: | Vertically Integrated |
| Country: | United States |
| Employees: | > 400 (October 2019) |
| Established: | 2012 |
| CEO: | Kyle Kingsley, M.D. |
Vireo – Company Financials
Vireo auditor: Davidson & Company LLP
Balance Sheet (06/30/20)
Income Statement (06/30/20)
Cash Flow Statement (06/30/20)
SEDAR Filings
Click here to view all SEDAR filings for Vireo Health International, Inc.
- 2020-Q2 Financials
- 2020-Q2 MD&A
- 2019 Financials
- 2019 MD&A
- 2018 Financials
- 2018 MD&A
- Filing Statement
Vireo Health is expected to report its Q3 financials by 11/30
Visit Vireo Health International, Inc.
at www.vireohealth.com.
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Vireo Health International, Inc. is a client of NCV Media, LLC. Read our full disclaimer.